Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04686604 · ClinicalTrials.gov registry record · NA
PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure in the Inpatient Setting
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 1,012
- Enrollment target
NCT04686604 is a NA study that has completed, run by Yale University. The registered enrollment target is 1,012 participants.
The verdict
NCT04686604, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,012 participants
- Enrollment target
Study Summary
A randomized single-blind interventional trial to test the effectiveness of an electronic medical record-based best practice alert recommending evidence-based medical therapies versus usual care in inpatient adult patients presenting with heart failure with reduced ejection fraction.
Interventions
- OTHER Best practice alert for the notification of patient HFrEF and recommended evidence-based medical therapies (NO drugs are being administered in this trial)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,012 participants |
| Start Date | 2021-07-07 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04686604
The ClinicalTrials.gov registry entry for NCT04686604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,012 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Best practice alert for the notification of patient HFrEF and recommended evidence-based medical therapies (NO drugs are being administered in this trial) is the first listed.
NCT04686604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04686604 about?
NCT04686604 is a clinical study titled "PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure in the Inpatient Setting". A randomized single-blind interventional trial to test the effectiveness of an electronic medical record-based best practice alert recommending evidence-based medical therapies versus usual care in inpatient adult patients presenting with heart failure with reduced ejection fraction.
What is the current status of trial NCT04686604?
This trial is currently completed. It is a NA study. The enrollment target is 1,012 participants. The study started on 2021-07-07. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT04686604?
The interventions under investigation include: Best practice alert for the notification of patient HFrEF and recommended evidence-based medical therapies (NO drugs are being administered in this trial) (OTHER).
Who is sponsoring clinical trial NCT04686604?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.